Kristian Hellenkamp

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

Journal: The New England journal of medicine

Published: May 27, 2026

Finerenone in diabetic chronic kidney disease-Real-world insights including patients with HFpEF or HFmrEF.

Finerenone in diabetic chronic kidney disease-Real-world insights including patients with HFpEF or HFmrEF.

Journal: ESC heart failure

Published: August 15, 2025

Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction.

Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction.

Journal: Med (New York, N.Y.)

Published: December 18, 2024

Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction.

Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction.

Journal: Cardiovascular diabetology

Published: November 17, 2024

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: December 05, 2023

Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.

Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.

Journal: International journal of cardiology

Published: December 04, 2023

Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial.

Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial.

Journal: JAMA cardiology

Published: September 20, 2023

Engineered heart muscle allografts for heart repair in primates and humans.

Engineered heart muscle allografts for heart repair in primates and humans.

Journal: Nature

Published: March 19, 2023

Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation.

Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: January 13, 2023

Concomitant latent pulmonary vascular disease leads to impaired global cardiac performance in heart failure with preserved ejection fraction.

Concomitant latent pulmonary vascular disease leads to impaired global cardiac performance in heart failure with preserved ejection fraction.

Journal: European journal of heart failure

Published: September 30, 2022

Management of chronic heart failure: state of the art according to the 2021 guideline

Management of chronic heart failure: state of the art according to the 2021 guideline

Journal: Innere Medizin (Heidelberg, Germany)

Published: August 04, 2022

Structured, Harmonized, and Interoperable Integration of Clinical Routine Data to Compute Heart Failure Risk Scores.

Structured, Harmonized, and Interoperable Integration of Clinical Routine Data to Compute Heart Failure Risk Scores.

Journal: Life (Basel, Switzerland)

Published: May 06, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026